BCRX: BioCryst Pharmaceuticals Inc

8.22 USD 0.03 (0.36%)

セクター: ヘルスケアベース: US Dollar 利益通貨: US Dollar

BCRXの今日の為替レートは、-0.36%変化しました。日中、通貨は1あたり8.12の安値と8.39の高値で取引されました。

BioCryst Pharmaceuticals Incダイナミクスに従います。リアルタイムの相場は、市場の変化に迅速に対応するのに役立ちます。異なる時間枠に切り替えることで、為替レートの傾向とダイナミクスを分、時間、日、週、月単位で監視できます。この情報を使用して、市場の変化を予測し、十分な情報に基づいて取引を決定してください。

全画面チャート

BCRX News

Zacks 14:00 Analysts Estimate Esperion Therapeutics (ESPR) to Report a Decline in Earnings: What to Look Out for
Zacks 14:00 BioCryst Pharmaceuticals (BCRX) Reports Next Week: Wall Street Expects Earnings Growth
Investing 17:32 BioCryst stock undervalued ahead of Q2 earnings, says RBC Capital
Investing 17:20 Citizens JMP downgrades Clearside Biomedical stock rating as company pauses R&D
Investing 11:46 Clearside Biomedical stock falls after announcing strategic alternatives exploration
Seeking Alpha 19:24 Astria: Betting On Navenibart In The Crowded HAE Arena
Investing 11:05 BioCryst Pharmaceuticals appoints Babar Ghias as CFO
Benzinga 14:41 BioCryst Just Ditched Its Europe Business — Here's Why Investors Are Cheering - BioCryst Pharma (NASDAQ:BCRX)
Investing 12:19 BioCryst stock rises after $264 million sale of European ORLADEYO business
Investing 11:04 BioCryst to sell European ORLADEYO business to Neopharmed for $264M
Investing 11:04 FDA extends review period for BioCryst pediatric drug application to December
Investing 11:09 BioCryst reports long-term efficacy of ORLADEYO in HAE treatment
Investing 11:06 Colombia approves BioCryst’s oral HAE treatment ORLADEYO
Investing 14:15 BioCryst at Goldman Sachs Conference: Strategic Growth and Profitability
Seeking Alpha 21:26 Eton Pharmaceuticals: Rapid Revenue Growth And Pipeline Catalysts Point To More Upside
Investing 11:05 Netherlands approves BioCryst’s HAE drug ORLADEYO for reimbursement
Investing 11:36 biocryst pharmaceuticals extends cfo consulting agreement
Investing 11:32 BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Investing 11:32 BioCryst to Present New Data at 2025 Meeting of the European Academy of Allergy and Clinical Immunology
Investing 11:06 BioCryst reports efficacy of HAE drug across age groups
Investing 13:44 Cantor Fitzgerald maintains overweight on Metsera shares
Investing 11:28 BioCryst to Present at Upcoming Investor Conferences
Investing 11:05 BioCryst reports ORLADEYO reduces severe HAE attack rates
Benzinga 21:29 BioCryst Pharmaceuticals Soars 23% In One Session - Here's Why It Surprised Investors - BioCryst Pharma (NASDAQ:BCRX)

1日のレンジ

8.12 8.39

1年のレンジ

6.01 11.31

以前の終値: 8.09
始値: 8.25

買値: 8.22
買値: 8.52

安値: 8.12
高値: 8.39

出来高: 5.803 K

1日の変化: -0.36%
1ヶ月の変化: -8.46%

6ヶ月の変化: 6.48%
1年の変化: 12.60%

30 7月, 水曜日